Downregulation of COX-2 expression and function in CRC cells by SST is thought to occur through activation of SST3 or SST5, and these effects contribute to the antiproliferative effects of SST on tumor cells [169]. The gene discussed is SSTR5; the disease is colorectal carcinoma.